CVR: 29428514
Secondary names: BIO-BEDST ApS, LIPLASOME ApS
LIPLASOME PHARMA ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans-Henrik Horsted Eriksen. The company is owned by BAGGER-SØRENSEN & CO. A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK -28,000 and a net result of DKK 62,000 compared with DKK -36,000 the year before. Equity amounted to DKK 2,377,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at videreudvikle og kom¬mer¬cialisere selskabets delivery tek-nologi primært indenfor cancerbehandling.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -28 t. | 62 t. | 2.4 mio. | 2.4 mio. | 0 | |
| 2024 | -53 t. | -36 t. | 2.3 mio. | 2.3 mio. | 0 | |
| 2023 | -29 t. | -20 t. | 2.4 mio. | 2.4 mio. | 0 | |
| 2022 | 2.2 mio. | 2.2 mio. | 2.4 mio. | 2.4 mio. | - | |
| 2021 | 108 t. | 98 t. | 186 t. | 175 t. | - | |
| 2020 | -133 t. | -156 t. | 1.5 mio. | 77 t. | - | |
| 2019 | -81 t. | -33.6 mio. | 571 t. | 233 t. | - | |
| 2018 | -61 t. | -54 t. | 38.3 mio. | 33.8 mio. | - | |
| 2017 | -65 t. | -55 t. | 38.5 mio. | 33.8 mio. | 0 | |
| 2016 | -328 t. | -309 t. | 38.2 mio. | 33.9 mio. | 0 | |
| 2015 | -1.7 mio. | -2.5 mio. | 40.7 mio. | 34.2 mio. | 2 | |
| 2014 | -1.5 mio. | -2.4 mio. | 34.4 mio. | 31.8 mio. | 2 | |
| 2013 | -1.2 mio. | -147 t. | 35.1 mio. | 34.2 mio. | 2 | |
| 2012 | -850 t. | -3 mio. | 20.6 mio. | 19.7 mio. | 2 |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
LIPLASOME PHARMA ApS has published its annual report for 2025. Gross profit came to DKK -28,000, and the net result was DKK 62,000.
LIPLASOME PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -53,000, and the net result was DKK -36,000.
LIPLASOME PHARMA ApS has published its annual report for 2023. Gross profit came to DKK -29,000, and the net result was DKK -20,000.
LIPLASOME PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 2,202,000, and the net result was DKK 2,196,000.
As of October 14, 2022, BAGGER-SØRENSEN & CO. A/S is registered as an owner of LIPLASOME PHARMA ApS with an ownership share of 90%.
LIPLASOME PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 108,000, and the net result was DKK 98,000.
LIPLASOME PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -133,000, and the net result was DKK -156,000.
LIPLASOME PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -81,000, and the net result was DKK -33,551,000.
LIPLASOME PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -61,000, and the net result was DKK -54,000.
LIPLASOME PHARMA ApS has published its annual report for 2017. Gross profit came to DKK -65,000, and the net result was DKK -55,000.
LIPLASOME PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -328,000, and the net result was DKK -309,000.
LIPLASOME PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -1,723,000, and the net result was DKK -2,491,000.
As of February 15, 2016, Sanjay Kumar Sehgal has joined the board of directors of LIPLASOME PHARMA ApS.
As of February 15, 2016, Peter Buhl has left the board of directors of LIPLASOME PHARMA ApS.
As of February 15, 2016, Duncan Moore has left the board of directors of LIPLASOME PHARMA ApS.
LIPLASOME PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -1,519,000, and the net result was DKK -2,401,000.
LIPLASOME PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -1,161,000, and the net result was DKK -147,000.
LIPLASOME PHARMA ApS has published its annual report for 2012. Gross profit came to DKK -850,000, and the net result was DKK -3,002,000.
As of August 24, 2012, Hans-Henrik Horsted Eriksen has joined the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, John Riis Mortensen has joined the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, Duncan Moore has joined the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, Torben Brøgger-Mikkelsen has left the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, Holger Bagger-Sørensen has left the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, Torben Vilsgaard has left the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, Steen Bagger-Sørensen has left the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, Claus Bagger-Sørensen has left the board of directors of LIPLASOME PHARMA ApS.
As of August 24, 2012, Hans-Henrik Horsted Eriksen is registered as adm. dir. of LIPLASOME PHARMA ApS.
As of June 1, 2011, Torben Vilsgaard has joined the board of directors of LIPLASOME PHARMA ApS.
As of June 1, 2011, Ole Lund has left the board of directors of LIPLASOME PHARMA ApS.
As of December 31, 2008, Peter Buhl has joined the board of directors of LIPLASOME PHARMA ApS.
As of May 26, 2008, EY Godkendt Revisionspartnerselskab has been appointed auditor of LIPLASOME PHARMA ApS.
As of May 26, 2008, K P M G C JESPERSEN ÅRHUS I/S has stepped down as auditor of LIPLASOME PHARMA ApS.
As of February 8, 2006, K P M G C JESPERSEN ÅRHUS I/S has been appointed auditor of LIPLASOME PHARMA ApS.
As of February 8, 2006, Torben Brøgger-Mikkelsen has joined the board of directors of LIPLASOME PHARMA ApS.
As of February 8, 2006, Holger Bagger-Sørensen has joined the board of directors of LIPLASOME PHARMA ApS.
As of February 8, 2006, Ole Lund has joined the board of directors of LIPLASOME PHARMA ApS.
As of February 8, 2006, Steen Bagger-Sørensen has joined the board of directors of LIPLASOME PHARMA ApS.
As of February 8, 2006, Claus Bagger-Sørensen has joined the board of directors of LIPLASOME PHARMA ApS.
LIPLASOME PHARMA ApS was founded on February 8, 2006.
Companies in the same industry and area
CVR 25577922
CVR 42036099
CVR 30738276
CVR 44395665
CVR 44626896
companydata.dk